ADAR1 could be a potential diagnostic target for intrauterine infection patients
Keiichiro Nakamura, Kunitoshi Shigeyasu, Thuy Ha Vu, Jota Maki, Kazuhiro Okamoto, Hisashi Masuyama · 2024
Read ADAR1 could be a potential diagnostic target for intrauterine infection patients by Keiichiro Nakamura, Kunitoshi Shigeyasu, Thuy Ha Vu, Jota Maki, Kazuhiro Okamoto, Hisashi Masuyama (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11599928.txt.
Description
Keiichiro Nakamura and five co-authors propose a blood and tissue marker for infections inside the womb during pregnancy, in a 2024 paper. Such infections can inflame the membranes around the baby and the cord, and no good test exists.
The team measured RNA-editing enzymes in membrane and cord samples from 83 patients. One enzyme, ADAR1, separated infected from uninfected patients better than rival enzymes or standard inflammation markers. In cell tests, a common genital microbe switched ADAR1 on and damped the cells' antiviral signals. High ADAR1 levels were strongly tied to both membrane and cord inflammation in the patient data. The authors put ADAR1 forward as a diagnostic target needing wider testing.
Catalog record
| CREATOR | Keiichiro Nakamura, Kunitoshi Shigeyasu, Thuy Ha Vu, Jota Maki, Kazuhiro Okamoto, Hisashi Masuyama |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |